Marker Therapeutics (MRKR) Share-based Compensation (2010 - 2026)
Marker Therapeutics (MRKR) posted Share-based Compensation of $195,735 for Q2 2026, compared with $13,986 a year earlier and up 9.7% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Marker Therapeutics was $518,567, up 4.3% year-over-year; for FY2025, it was $537,540, up 118.6% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- In prior years, Marker Therapeutics' Share-based Compensation was $245,864 in FY2024 (-71.4%), $858,269 in FY2023 (-74.0%), $3.3 million in FY2022 (-44.6%) and $5.96 million in FY2021 (+14.1%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q1 2025.
- On a year-over-year basis, Share-based Compensation increased in two of the last seven quarters, with growth averaging 27.8%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2025, with growth of 377.4%; the weakest was Q1 2024, with a decline of 88.0%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $178,422 (Q1 2026), $111,131 (Q4 2025) and $33,279 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn | - |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Marker Therapeutics | 19.48 Mn | -40.42 Mn | - | 195,735.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195,735.00 |
| Mar 31, 2026 | 178,422.00 |
| Dec 31, 2025 | 111,131.00 |
| Sep 30, 2025 | 33,000.00 |
| Jun 30, 2025 | 13,986.00 |
| Mar 31, 2025 | 379,144.00 |
| Dec 31, 2024 | 50,544.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 79,417.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 175,000.00 |
| Jun 30, 2023 | 606,000.00 |
| Mar 31, 2023 | 660,000.00 |
| Dec 31, 2022 | 717,000.00 |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | 1.47 Mn |
API Access
Marker Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();